Public annual accounts

Vitamine J financials

Name: Vitamine J financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Vitamine J, with comparable measures and links to available source documents.

Company overview

Registry number

0805914206

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for Vitamine J

2025 versus 2024

Operating line: €40,539
EBITDA: €39,333
Total assets: €75,886
Equity: €53,425

EBITDA margin +97% · Equity ratio +70.4%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€40,539	€39,333	€75,886	€53,425	-
202431 Dec 2024	€28,890	€28,726	€43,583	€26,836	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report